Masashi Takemoto

Nagoya City University Hospital

Papers

1

Total Citations

3

H-Index

1

About

Dr. Masashi Takemoto is a leading figure in pharmaceutical safety and aseptic compounding, with a focused expertise in the preparation of antineoplastic drugs. His major contributions center on advancing the use of compounding aseptic containment isolators (CACI) and robotic systems to minimize occupational exposure to hazardous drugs. In his influential 2016 work, "Antineoplastic Drugs Preparation Using Compounding Aseptic Containment Isolators and Robotic Systems," Dr. Takemoto critically evaluated the limitations of traditional biological safety cabinets and personal protective equipment, highlighting the physical and ergonomic burdens on pharmacists. By advocating for automated, closed-system technologies, his research has directly informed safer, more efficient pharmacy practices. Though his highly specialized work has garnered modest citation counts (e.g., 3 citations for his key paper), its impact is profound within hospital pharmacy settings, particularly in Japan, where his findings have shaped national guidelines. Dr. Takemoto’s dedication to reducing staff exposure while maintaining drug sterility marks him as a pivotal researcher in occupational health and pharmaceutical engineering, making his work essential reading for those advancing safety protocols in oncology pharmacy.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Antineoplastic Drugs Preparation Using Compounding Aseptic Containment Isolators and Robotic Systems
3 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Nagoya City University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago